E-Z-Em of Westbury, NY, announced this month that it has signedan agreement with Bowman Gray School of Medicine in Winston-Salem,NC, to develop an oral contrast agent for virtual colonoscopyprocedures under investigation at the hospital. The agent
E-Z-Em of Westbury, NY, announced this month that it has signedan agreement with Bowman Gray School of Medicine in Winston-Salem,NC, to develop an oral contrast agent for virtual colonoscopyprocedures under investigation at the hospital. The agent willminimize artifacts in 3-D images of the colon that can obscureor mimic polyps in virtual colonoscopy simulations. Virtual colonoscopyis being developed as an alternative to video-based colonoscopyscreening (SCAN 7/19/95).
In other news, E-Z-Em has introduced a new remote-controlledCT contrast injection system, PercuPump II. E-Z-Em used feedbackfrom radiologists and technologists in designing the system, whichuses a touch-screen remote control and features an optional thermalprinter to print a record of each patient's procedure.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.